Passer au contenu principal

pantothenate kinase 2

La PANK2 gene provides instructions for making an enzyme called pantothenate kinase 2. This enzyme is active in specialized cellular structures called mitochondria, which are the cell's energy-producing centers. Within mitochondria, pantothenate kinase 2 regulates the formation of a molecule called coenzyme A. Coenzyme A is found in all living cells, where it is essential for the body's production of energy from carbohydrates, fats, and some protein building blocks (amino acids).

Sélections vidéo pour Gènes
Bibliothèque vidéo

Normal function

La PANK2 gene provides instructions for making an enzyme called pantothenate kinase 2. This enzyme is active in specialized cellular structures called mitochondria, which are the cell's energy-producing centers. Within mitochondria, pantothenate kinase 2 regulates the formation of a molecule called coenzyme A. Coenzyme A is found in all living cells, where it is essential for the body's production of energy from carbohydrates, fats, and some protein building blocks (amino acids).

PANK2 is one of four human genes that provide instructions for making versions of pantothenate kinase. The functions of these different versions probably vary among tissue types and parts of the cell. The version produced by the PANK2 gene is active in cells throughout the body, including nerve cells in the brain.

Conditions referring to this gene or chromosome

Other names

NBIA1

PANK2_HUMAN

pantothenate kinase 2 (Hallervorden-Spatz syndrome)

pantothenic acid kinase

Related patient information and medicines

Cancer de la bouche

Patient information leaflet

Cancer de la bouche

Epidermal growth factor receptor monoclonal antibody (EGFR mAb) is one form of targete... Cetuximab is an EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin (rIL-2) is.

Myélofibrose

Patient information leaflet

Myélofibrose

Myélofibrose is a condition affecting the bone marrow ... The gene mutation that occurs in most people affected by myelofibrosis is a mutation in Janus Kinase 2 (JAK2). Dr Sarah Jarvis, December 2021 NICE guidance on drug treatments for myelofibrosis Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis The National.

dystrophie musculaire

Patient information leaflet

dystrophie musculaire

Becker's muscular dy. Symptoms start in the teenage years or early 20s. The wea... Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to another cause. MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase.

Cancer primitif du foie

Patient information leaflet

Cancer primitif du foie

Some conditions which cause persistent inflammation of the gut increase the risk slightly of developing an uncommon type of primary liver cancer (called. Smoking There is some evidence that smoking Smoking can increase the risk. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine.

Maladies de stockage du glycogène

Patient information leaflet

Maladies de stockage du glycogène

Maladies de stockage du glycogène are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Arthrite juvénile idiopathique

Patient information leaflet

Arthrite juvénile idiopathique

As they are relatively new medicines, there are still studies being done to establish whether there are any long-term health risks from taking them. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is another new drug. It belongs to a type of drug called JAK kinase inhibitors. It is sometimes used if.

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 18 avr. 2023 | Dernière version
  • 1 Oct 2006 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.